You are here: Industry Insights > vaccine

News List

Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age Drugs
November 26, 2021
Pfizer Inc. and BioNTech SE today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age...
COVID Protection Wanes After 2 Doses of Pfizer Vaccine: Study Drugs
November 26, 2021
Protection can gradually fade after a second dose of the COVID-19 vaccine by Pfizer-BioNTech, which suggests that a booster shot might be necessary, researchers report.
Health Canada approves Johnson & Johnson’s single-dose Covid-19 vaccine Pharmaceutical-Business-Review
November 26, 2021
Health Canada has granted full approval to Janssen Pharmaceutical Companies of Johnson & Johnson’s single-dose Covid-19 vaccine for the disease prevention in people aged 18 years and above.
Health Canada approves J&J Covid-19 vaccine for use in adults Pharmaceutical-Technology
November 26, 2021
Health Canada has granted full approval for Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for active immunisation to prevent infection in adults aged 18 years and older.
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore Pharmaceutical-Technology
November 26, 2021
US-based biotechnology firm Novavax has filed an application seeking interim authorisation from the Singapore Health Sciences Authority (HSA) for its Covid-19 vaccine, NVX-CoV2373, under the Pandemic Special Access Route.
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing prnasia
November 25, 2021
GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp...
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study ExpressPharma
November 25, 2021
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older AmericanPharmaceuticalReview
November 25, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.
Some Republicans Calling for 'Natural Immunity' Exception to COVID Vaccines Drugs
November 25, 2021
Republican lawmakers in several states are pushing vaccine mandate exemptions for workers who have so-called natural immunity due to a previous COVID-19 infection.
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron Pharmaceutical-Technology
November 25, 2021
Norwegian vaccine and immunotherapy-focused biopharma Nykode Therapeutics started off in 2007 as Vaccibody, before rebranding this week to signal its significant growth and transformation plans.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page